← Back to Portfolio

Astex Pharmaceuticals

Astex uses its fragment based drug discovery technology to identify and develop new medicines, primarily for the treatment of cancer and antiviral diseases. The company has a number of internally developed therapeutic candidates in clinical trials. Astex merged with SuperGen in July 2011 and was acquired by Otsuka Pharma for $860 million in September 2013.

Location Cambridge, England
Website www.astx.com